[url="]Agenus[/url] Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced the

Completion Removes the Remaining Conversion Overhang Associated With the Company's Convertible N

Completion Removes the Remaining Conversion Overhang Associated With the Company's Convertible Note

Maison Solutions Inc. (Nasdaq:MSS) (the "Company") today announced that, on August 20, 2026,

MONTEREY PARK, CA / ACCESS Newswire / August 25, 2026 / Maison Solutions Inc. (Nasdaq:MSS) (the "Com

ImmunoForge Selected for the Ministry of SMEs and Startups' 'Global TIPS R&D' Program… "Expansion

KEYS stock rose 3% in pre-market trading due to strong financial results and guidance. Other gainers

Maison Solutions shares jumped 40.76% after hours Tuesday following an insider sale disclosed in an

FDA written feedback provides alignment on a potential pivotal Part B expansion of the ongoing REO 0

Gainers IP Strategy Holdings (NASDAQ:IPST) shares rose 13.2% to $8.37 during Monday's after-mar

Innovent Announces First Patient Dosed in Pivotal Registrational Study of IBI363/TAK-928 (PD-1/IL-2Î

MONTEREY PARK, CA / ACCESS Newswire / August 5, 2026 / Maison Solutions Inc. (Nasdaq:MSS) ("Maison S

Opportunity to buy undervalued consumer staples stocks with RSI below 30. Recent developments and tr

Maison Solutions Inc. (NASDAQ:MSS) ("Maison Solutions" or the "Company"), a specialt

MONTEREY PARK, CA / ACCESS Newswire / July 29, 2026 / Maison Solutions Inc. (Nasdaq:MSS) ("Maison So

Maison Solutions Inc. (NASDAQ:MSS) ("Maison Solutions" or the "Company"), a specialt

MONTEREY PARK, CA / ACCESS Newswire / July 27, 2026 / Maison Solutions Inc. (NASDAQ:MSS) ("Maison So

MONTEREY PARK, CA / ACCESS Newswire / July 24, 2026 / Maison Solutions Inc. (NASDAQ:MSS) ("Maison So

Harbour BioMed Announces Positive Profit Alert for 2026 Interim Results, Marking Seventh Consecutive

Maison Solutions will implement a 1-for-5 reverse stock split of its outstanding shares of Class A c

MONTEREY PARK, CA / ACCESS Newswire / July 20, 2026 / Maison Solutions Inc. (NASDAQ:MSS) ("Maison So

July 15, 2026, ST. PETERSBURG, FL – Water Tower Research (www.watertowerresearch.com) has published

Half of planned clinical sites will be activated this month; more than 20 patients have been pre-ide

On July 2, 2026, Maison Solutions Inc. (the "Company") entered into an Equity Purchase Agree

Gainers Sadot Group (NASDAQ:SDOT) stock rose 22.1% to $61.7 during Monday's pre-market session.

Shares of Maison Solutions Inc (NASDAQ:MSS) rose sharply in pre-market trading. Maison Solutions ent

Maison Solutions (NASDAQ: MSS) rose 62.6% in pre-market trading after divesting some operations for

MONTEREY PARK, CA / ACCESS Newswire / July 3, 2026 / Maison Solutions Inc. (Nasdaq:MSS) ("Maison Sol

[url="]Agenus[/url] Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced tha

Maison Solutions Inc. (NASDAQ:MSS) ("Maison Solutions" or the "Company"), a specialt

MONTEREY PARK, CA / ACCESS Newswire / June 9, 2026 / Maison Solutions Inc. (Nasdaq:MSS) ("Maison Sol

Summit Therapeutics Inc. (NASDAQ: SMMT) today presented new results from the AK112-206 trial (NCT053

MONTEREY PARK, CA / ACCESS Newswire / May 25, 2026 / Maison Solutions Inc. (NASDAQ:MSS) ("Maison Sol

Maison Solutions Inc. (NASDAQ:MSS) ("Maison Solutions" or the "Company"), a specialt

Organon & Co (OGN) jumped 14.8% in pre-market trading as Sun Pharma agreed to acquire the compan

Top Wall Street analysts have changed their outlook on top names. For full analyst rating changes, i

Ascendiant Capital analyst Edward Woo maintains Maison Solutions (NASDAQ:MSS) with a Buy and lowe

Material Modifications to Rights of Security Holders. As previously disclosed in a Schedule 14C, fil

Ascendiant Capital analyst Edward Woo maintains Maison Solutions (NASDAQ:MSS) with a Buy and rais

Maison Solutions (NASDAQ:MSS) reported quarterly losses of $(0.23) per share. This is a 2200 percent